News

Published on 4 May 2024 on Insider Monkey via Yahoo Finance

23 Most Profitable Stocks of the Last 12 Months


Article preview image

In this article, we discuss the 23 most profitable stocks of the last 12 months. If you want to skip our detailed analysis of these stocks, go directly to 5 Most Profitable Stocks of the Last 12 Months. 

The United States stock market has come a long way since the turn of the millennium more than two decades ago. Emerging from the dotcom boom and bust without permanent damage, the economy has faced the financial meltdown of 2008, a tech-enabled boom that has resulted in trillion dollar valuations, and the pandemic crisis of 2020 that ground business to almost a complete halt across the globe. From 2003 to 2023, the benchmark S&P 500 has registered double digits annual returns thirteen times.

NASDAQ.MNST price evolution
NASDAQ.IDXX price evolution
NASDAQ.ANSS price evolution
NYSE.PFE price evolution
NYSE.MCO price evolution
NASDAQ.SNPS price evolution
NYSE.ROP price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Here’s Why Pfizer Inc. (PFE) Is Among The Stocks Targeted By Activist Hedge...

We recently compiled a list of the 15 Stocks Targeted By Activist Hedge Funds. In this article, w...

Insider Monkey · via Yahoo Finance 3 Jan 2025

The Zacks Analyst Blog Berkshire Hathaway, The Home Depot, Pfizer and AMREP

Research analysts discuss the latest news and events impacting stocks and the financial markets....

Zacks · via Yahoo Finance 3 Jan 2025

Jim Cramer’s Take on Pfizer Inc. (PFE): Bold Predictions for the Future

We recently compiled a list of the Jim Cramer’s Bold Predictions About These 10 Healthcare Stocks...

Insider Monkey · via Yahoo Finance 1 Jan 2025

Options run thin for Sangamo Therapeutics after Pfizer deal crashes - San...

Pfizer Inc. abruptly ended a key hemophilia A gene therapy collaboration with Sangamo Therapeutic...

The Business Journals 31 Dec 2024

Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy...

On Monday, Sangamo Therapeutics, Inc. (NASDAQ:SGMO) regained the development and commercializatio...

Benzinga · via Yahoo Finance 31 Dec 2024

Pfizer: 4 Reasons to Buy The Pharma Giant Going Into 2025 | Investing.com

Stocks Analysis by MarketBeat.com (Jea Yu) covering: Eli Lilly and Company, Pfizer Inc. Read...

Investing.com 31 Dec 2024

Is Pfizer Inc. (PFE) the Best Pharma Dividend Stock to Buy In 2024?

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article...

Insider Monkey · via Yahoo Finance 30 Dec 2024

25 Worst Stocks to Own in January

For cautious investors, this could be a signal to steer clear of Pfizer Inc (NYSE:PFE), a stock w...

Schaeffer's Investment Research · via Yahoo Finance 30 Dec 2024

Is Pfizer Inc. (PFE) the Best Dividend Stock to Buy Under $50?

We recently compiled a list of the 13 Best Dividend Stocks to Buy Under $50. In this article, we ...

Insider Monkey · via Yahoo Finance 25 Dec 2024

Is Pfizer (NYSE:PFE) A Risky Investment?

It's only natural to consider a company's balance sheet when you examine how risky it is, since d...

Simply Wall St. · via Yahoo Finance 25 Dec 2024